３０錠（10錠シート×３）
1,600円（送料別途300円）
メールにてお申し込み下さい
Cafergot
Treatment of migraine attacks
Composition Each tablet of cafergot
Ergotamine tartrate 1mg
caffeine 100mg
Indications
Acute attacks of migraine and related types of vascular headache.
Dosage and administration
Adults and children over12years of age.
cafergot should be given at the first symptoms of an attack, an initial dose of 1-2 tablets, if relief is not obtained within half an hour, a further tablets should be administered: this may be repeated at half-hourly intervals but the maximum daily dose should not more than 6 tablets and the maximum weekly dose should not more than 10 tablets.
Children under 12 years of age: as prescribed by the physician.
Contraindications
Nonvascular headache, vascular disease or hypertension, hepatic or renal insufficiency, pregnancy or breast-feeding, peptic ulcer, malnutrition, septic condition or hypersensitivity to ergot.
Precautions
If symptoms such as tingling, cold, peripheral or muscle pain, stomach pain, nausea, vomiting, diarrhoea, and headache occur, the drug should be discontinued at once and the physician consulted.
Note
cafergot should not be used for preventive(interval)treatment and should not be taken frequently over a prolonged period of time.
Interactions
The concomitant use of troleandomycin, erythromycin or josamycin, and ergotamine can result in an elevated concentration of ergotamine in the plasma, thereby causing untoward peripheral vasoconstriction. Among patients treated concomitantly With ergotamine and propranolol a few cases of vasospastic reactions have been reported.
Side effects
Nausea and vomiting. Paraesthesia, pain and weakness in the extremities or peripheral vasoconstriction may occur in susceptible patients or following prolonged treatment. If symptoms, e.g. tingling in the fingers or toes occur, the drug should be discontinued at once and the physician consulted. If ergotamine-containing drugs are used excessively over years, they may induce fibrotic changes, in particular of the pleura and the retroperitoneum.